245 related articles for article (PubMed ID: 27805826)
1. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
Gerberick GF
Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
[TBL] [Abstract][Full Text] [Related]
2. The adverse outcome pathway for skin sensitisation: Moving closer to replacing animal testing.
Schultz TW; Dimitrova G; Dimitrov S; Mekenyan OG
Altern Lab Anim; 2016 Oct; 44(5):453-460. PubMed ID: 27805828
[TBL] [Abstract][Full Text] [Related]
3. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
Roberts DW; Patlewicz G
J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
[TBL] [Abstract][Full Text] [Related]
4. The activity of methacrylate esters in skin sensitisation test methods II. A review of complementary and additional analyses.
Kimber I
Regul Toxicol Pharmacol; 2021 Feb; 119():104821. PubMed ID: 33186628
[TBL] [Abstract][Full Text] [Related]
5. Integrated decision strategies for skin sensitization hazard.
Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
[TBL] [Abstract][Full Text] [Related]
6. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
[TBL] [Abstract][Full Text] [Related]
7. Skin sensitizing effects of sulfur mustard and other alkylating agents in accordance to OECD guidelines.
Steinritz D; Lang S; Popp T; Siegert M; Rothmiller S; Kranawetvogl A; Schmidt A; John H; Gudermann T; Thiermann H; Kehe K
Toxicol Lett; 2019 Oct; 314():172-180. PubMed ID: 31404593
[TBL] [Abstract][Full Text] [Related]
8. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
[TBL] [Abstract][Full Text] [Related]
9. Peptide reactivity assays for skin sensitisation - scope and limitations.
Roberts DW
Crit Rev Toxicol; 2022 Jul; 52(6):420-430. PubMed ID: 36542542
[TBL] [Abstract][Full Text] [Related]
10. From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.
MacKay C; Davies M; Summerfield V; Maxwell G
ALTEX; 2013; 30(4):473-86. PubMed ID: 24173169
[TBL] [Abstract][Full Text] [Related]
11. Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach.
Natsch A; Gerberick GF
ALTEX; 2022; 39(4):647-655. PubMed ID: 35404468
[TBL] [Abstract][Full Text] [Related]
12. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
[TBL] [Abstract][Full Text] [Related]
13. Prediction of skin sensitization potency sub-categories using peptide reactivity data.
Wareing B; Urbisch D; Kolle SN; Honarvar N; Sauer UG; Mehling A; Landsiedel R
Toxicol In Vitro; 2017 Dec; 45(Pt 1):134-145. PubMed ID: 28882705
[TBL] [Abstract][Full Text] [Related]
14. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation.
Natsch A; Ryan CA; Foertsch L; Emter R; Jaworska J; Gerberick F; Kern P
J Appl Toxicol; 2013 Nov; 33(11):1337-52. PubMed ID: 23576290
[TBL] [Abstract][Full Text] [Related]
15. Off to a good start? Review of the predictivity of reactivity methods modelling the molecular initiating event of skin sensitization.
Alépée N; Tourneix F; Singh A; Ade N; Grégoire S
ALTEX; 2023; 40(4):606-618. PubMed ID: 37314401
[TBL] [Abstract][Full Text] [Related]
16. Assessing skin sensitization hazard in mice and men using non-animal test methods.
Urbisch D; Mehling A; Guth K; Ramirez T; Honarvar N; Kolle S; Landsiedel R; Jaworska J; Kern PS; Gerberick F; Natsch A; Emter R; Ashikaga T; Miyazawa M; Sakaguchi H
Regul Toxicol Pharmacol; 2015 Mar; 71(2):337-51. PubMed ID: 25541156
[TBL] [Abstract][Full Text] [Related]
17. The adverse outcome pathway concept: A basis for developing regulatory decision-making tools.
Delrue N; Sachana M; Sakuratani Y; Gourmelon A; Leinala E; Diderich R
Altern Lab Anim; 2016 Oct; 44(5):417-429. PubMed ID: 27805824
[TBL] [Abstract][Full Text] [Related]
18. Application of Spectro-DPRA, KeratinoSens™ and h-CLAT to estimation of the skin sensitization potential of cosmetics ingredients.
Cho SA; Choi M; Park SR; An S; Park JH
J Appl Toxicol; 2020 Feb; 40(2):300-312. PubMed ID: 31680285
[TBL] [Abstract][Full Text] [Related]
19. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
[TBL] [Abstract][Full Text] [Related]
20. Prediction of skin sensitization potency using machine learning approaches.
Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
